Main S, Handy R, Wilton J, Smith S, Williams L, Fou LD, et al. (December 2006). "A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacy". The Journal of Pharmacology and Experimental Therapeutics. 319 (3): 1395–404. doi:10.1124/jpet.106.110734. PMID16973884. S2CID20865759.
Main S, Handy R, Wilton J, Smith S, Williams L, Fou LD, et al. (December 2006). "A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacy". The Journal of Pharmacology and Experimental Therapeutics. 319 (3): 1395–404. doi:10.1124/jpet.106.110734. PMID16973884. S2CID20865759.
Ding C, Li J, Zhang X (November 2004). "Bertilimumab Cambridge Antibody Technology Group". Current Opinion in Investigational Drugs. 5 (11): 1213–8. PMID15573873.
semanticscholar.org
api.semanticscholar.org
Main S, Handy R, Wilton J, Smith S, Williams L, Fou LD, et al. (December 2006). "A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacy". The Journal of Pharmacology and Experimental Therapeutics. 319 (3): 1395–404. doi:10.1124/jpet.106.110734. PMID16973884. S2CID20865759.
